The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- New Bio-Implant for Spinal Cord Repair
- Seattle jury awards $24M in lawsuit against stem cell center
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
- More Sensitive Cell Therapy May Be a HIT Against Solid Cancers
- New iron nanomaterial wipes out cancer cells without harming healthy tissue


